|
Showing 1 - 3 of
3 matches in All Departments
This cutting-edge reference book discusses the intervention of
artificial intelligence in the fields of drug development, modified
drug delivery systems, pharmaceutical technology, and medical
devices development. The comprehensive book includes an overview of
Artificial intelligence in pharmaceutical sciences and applications
in the drug discovery and development process. It discusses the
role of machine learning in the automated detection and sorting of
pharmaceutical formulations. It covers nanosafety, and the role of
AI in predicting potential adverse biological effects. Key features
– Includes lucid, step-by-step instructions to apply artificial
intelligence and machine learning in pharmaceutical sciences
Explores the application of artificial intelligence in nanosafety
and prediction of potential hazards Covers application of
artificial intelligence in drug discovery and drug development
Reviews the role of artifical intelligence in assessment of
pharmaceutical formulations Provides AI solutions for experts in
pharmaceutical and medical devices industry The book is meant for
academicians, students and industry experts in pharmaceutical
sciences, medicine, and pharmacology.
This book comprehensively reviews the proteins associated with
neurodevelopmental disorders, including autism spectrum disorder
(ASD) and attention deficit hyperactivity disorder (ADHD). It also
discusses the interactions of the associated-proteins, like
bromodomain-containing proteins (BCPs), kinases, synaptic proteins,
scaffolding proteins, transcriptional factors, and DNA-binding
proteins at the subcellular and molecular levels. The book also
explores the potential of these proteins as a druggable target and
a biomarker in the neurodevelopmental disorders. The book further
explores the recent advancements in understanding the important
role of epigenetic factors in predisposition to these diseases.
Lastly, it presents genetic factors that lead to variation in gene
expression in these diseases, disorders management via diet
intervention and the future potential of stem cell therapy.
This book comprehensively reviews the proteins associated with
neurodevelopmental disorders, including autism spectrum disorder
(ASD) and attention deficit hyperactivity disorder (ADHD). It also
discusses the interactions of the associated-proteins, like
bromodomain-containing proteins (BCPs), kinases, synaptic proteins,
scaffolding proteins, transcriptional factors, and DNA-binding
proteins at the subcellular and molecular levels. The book also
explores the potential of these proteins as a druggable target and
a biomarker in the neurodevelopmental disorders. The book further
explores the recent advancements in understanding the important
role of epigenetic factors in predisposition to these diseases.
Lastly, it presents genetic factors that lead to variation in gene
expression in these diseases, disorders management via diet
intervention and the future potential of stem cell therapy.
|
|